logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11351113 B1

PDFFull Text
Date of Patent:
Jun. 07, 2022

Filed:

May. 02, 2018

Bladder instillation composition with increased storage stability and containing chondroitin sulfate (4.5 mg/ml), hyaluronic acid (16 mg/ml) and phosphate buffer (ph 6.1 to 7.9), for the treatment of cystitis

Applicant:

Farco-pharma Gmbh, Cologne, DE;

Inventor:

Andreas Meier, Cologne, DE;

Assignee:

FARCO-PHARMA GMBH, Cologne, DE;

Attorneys:

Edward E. Sowers

Brannon Sowers & Cracraft PC

Primary Examiner:

Dale R Miller

Int. Cl.
CPC ...
A61K 31/728 (2006.01); A61K 31/737 (2006.01); A61K 9/00 (2006.01); A61P 13/10 (2006.01); A61K 9/08 (2006.01); A61K 33/14 (2006.01); A61K 47/02 (2006.01); A61M 3/02 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0034 (2013.01); A61K 9/08 (2013.01); A61K 31/728 (2013.01); A61K 31/737 (2013.01); A61K 33/14 (2013.01); A61K 47/02 (2013.01); A61M 3/0233 (2013.01); A61P 13/10 (2018.01);
Abstract

The invention relates to a combination drug with increased storage stability containing chondroitin sulfate (4.5 mg/ml), hyaluronic acid (16 mg/ml), a phosphate buffer (pH 6.1 to 7.9) and an electrolyte (e.g., an alkali salt, e.g., sodium chloride) for the treatment inflammations of the urogenital tract, in particular of the bladder, in particular for the treating cystitis, and to an instillation kit containing said drug.

Find Patent Forward Citations

Meier, Andreas. (2022). Bladder instillation composition with increased storage stability and containing chondroitin sulfate (4.5 mg/ml), hyaluronic acid (16 mg/ml) and phosphate buffer (ph 6.1 to 7.9), for the treatment of cystitis (U.S. Patent No. 11351113). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11351113

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…